The new genetics. Implications for clinical services in Britain and the United States

British Medical Journal

Volumn 316, Issue 7133, 1998, Pages 767-770

  Kinmonth, Ann Louise ^a   Reinhard, John ^b   Bobrow, Martin ^b   Pauker, Susan ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL GENETICS; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; FAMILY HISTORY; FEMALE; GENERAL PRACTICE; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC RISK; HEALTH SERVICE; HUMAN; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; SCREENING; SHORT SURVEY;

EID: 0032492368     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7133.767     Document Type: Short Survey

References (34)

1. Geller G, Tambor ES, Chase GA, Hofman KJ, Faden RR, Holtzmann NA. Incorporation of genetics in primary care practice. Will physicians do the counselling and will they be directive? Arch Fam Med 1993;2:1119-25.
2. Davison C. Predictive genetics: the cultural implications of supplying probable future. In: Marteau TM, Richards M, eds. The troubled helix:social and sociological implications of the new human genetics. Cambridge: Cambridge University Press 1996:317-30.
3. Bell J. The new genetics in clinical practice. BMJ 1998;316:618-20.
4. Sackett DL, Haynes B, Guyatt GH, Tugwell P. Clinical epidemiology, a basic science for clinical medicine: how to decide when to seek an early diagnosis. Boston: Little, Brown, 1991:167-70.
5. Harper PS. Genetic testing for commun diseases and health service provision. Lancet 1995;346:1654-6.
6. American Society of Human Genetics. Statement on genetic testing for breast and ovarian cancer predisposition-summary of recommendations. Am J Genet 1994;55:i-iv.
7. Payne V, Williams M, Cheadle J, Stott NC, Rowlands M, Stickle D, et al. Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. Clin Genet 1997;51:153-63.
8. Bachmann RP, Schoen EJ. Managed genetic care in a large HMO. HMO Practice 1996;10(2):54-8.
9. Burn J, Chapman P, Delhanty J, Wood C, Lalloo F, Cachon-Gonzalez MB, et al. The UK northern region genetic register for familial adenomatous polyposis coli. J Med Genet 1991;28:289-96.
10. Bulow S, Burn J, Neale K, Northover J, Vasen H. The establishment of a polyposis register. Int J Colorectal Dis 1993;8:34-8.
11. Davies F, Coles GA, Harper PS, Williams AJ, Evans C, Cochlin D. Polycystic kidney disease reevaluated: a population based study. QJ Med 1991;79:477-85.
12. Read AP, Kezin-Storrar L, Mountford RC, Elles RG, Harris R. A register based system for gene tracking in Duchenne muscular dystrophy. J Med Genet 1986;23:581-6.
13. Davison C, MacIntyre S, Davey-Smith G. The potential social impact of predictive genetic testing for susceptibility to common chronic diseases: a review and proposed research agenda. Sociology of Health and Illness 1991;16:340-71.
14. Parsons E, Atkinson P. Lay constructions of genetic risk. Sociology of Health and Illnes 1992;14:437-55.
15. Faden RR, Tambor ES, Chase GA, Geller G, Hoffman KJ, Holtzman NA. Attitudes of physicians and genetics professionals towards cystic fibrosis carrier screening. Am J Med Genet 1994;50:1-11.
16. Boulton M, Cummings C, Williamson R. The views of general practitioners on community carrier screening for cystic fibrosis. Br J Gen Pract 1996;16:299-301.
17. Doherty RA, Palomaki GE, Kloza EM, Erickson JL, Haddow JE. Couple based prenatal screening for cystic fibrosis in primary care settings. Prenat Diagn 1996;16:397-404.
18. Watson EK, Mayall E, Chapple J, Dalziel M, Harrington K, Williams C, et al. Screening of carriers of cystic fibrosis through primary health care services. BMJ 1991;303:504-7.
19. Loader S, Caldwell P, Kozyra A, Levenkron JC, Boehm CD, Kazazian HH, et al. Cystic fibrosis carrier population screening in the primary care setting. Am J Hum Genet 1996;59:234-47.
20. Brock DJ. Carrier screening in the community. J Inherit Metab Dis 1995;18:525-32.
21. Bekker H, Modell M, Denniss G, Silver A, Mathew C, Bobrow M, et al. Uptake of cystic fibrosis testing in primary care: supply push or demand pull? BMJ 1993;306;1584-6.
22. Harris HJ, Scotcher D, Hartley N, Wallace A, Craufurd D, Harris R. Cystic fibrosis carrier testing in early pregnancy by general practitioners. BMJ 1993;306:1580-3.
23. Cuckle HS, Richardson GA, Sheldon TA, Quirke P. Cost effectiveness of antenatal screening for cystic fibrosis. BMJ 1995;311:1460-3.
24. Clarke A. Commentary: Cost effectiveness of antenatal screening for cystic fibrosis. BMJ 1995;311:1463-4.
25. Marteau TM, Croyle RT. Psychological responses to genetic testing. BMJ 1998;316:693-6.
26. Progeny at http:/tprogeny2000.com/body.shtml
27. Hoskins KF, Stopfor JE, Calzone KE, Merajver SD, Rehbeck TR, Garber JE, et al. Assessment and counselling for women with a family history of breast cancer. A guide for clinicians. JAMA 1995;273:577-85.
28. Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Camineri A, Hughes C, et al. Controlled trial of pretest education approaches to enhance informed decision making for BRCA1 gene testing. J Natl Cancer Inst 1997;89:48-57.
29. Centre for Professional Ethics, University of Central Lancashire, Department Clinical Genetics. Royal Manchester Childrens' Hospital: The Gene Shop. Preston: The Centre [no date].
30. Teague KE, Brown JA, Meyer JM, Kahn MJ, Smith TJ, Keutzer KO, et al. Teaching efficacy of a medical education module on genetic testing for cancer. J Cancer Educ 1996;11:196-202.
31. Secretaries of State for Health, Scotland, and Wales. Choice and opportunity. Primary care: the future. London: Stationery Office, 1996. (Cm 3990.)
32. Mackay J, Pharoah P. A strategy for the management of individuals presenting with a family history of breast or ovarian cancer. Anglia and Oxford Health Authority, 1997.
33. Department of Health. First report to the NHS Central Research and Development Committee an the new genetics. Leeds: DoH, NHS Research and Development Directorate, 1995. (Chair: Martin Robrow.)
34. Department of Health. The genetics of common diseases: a second report to the NHS Central Research and Development Committee on the new genetics. Leeds: DoH, NHS Research and Development Directorate, 1995.